Efficacy of fludarabine, mitoxantrone, dexamethasone alternating with cyclophosphamide, doxorubicin, vincristine and prednisone (FMD/CHOP) in bulky follicular non-Hodgkin's lymphoma

被引：0
|
作者：
Wilder, DD
Ogden, JL
Jain, VK
机构：
[1] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[2] Texas Oncol PA, Dallas, TX USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2529
引用
收藏
页码：603A / 603A
页数：1
相关论文
共 50 条
  • [31] Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
    Lazzarino, R
    Orlandi, E
    Montillo, M
    Tedeschi, A
    Pagnucco, C
    Astori, C
    Corso, A
    Brusamolino, E
    Simoncini, L
    Morra, E
    Bernasconi, C
    ANNALS OF ONCOLOGY, 1999, 10 (01) : 59 - 64
  • [32] Reversibility of the effects of the chemotherapeutic regimen for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone, on the male rat reproductive system and progeny outcome
    Delbes, Geraldine
    Vaisheva, Farida
    Luu, Trang
    Marcon, Ludovic
    Hales, Barbara F.
    Robaire, Bernard
    REPRODUCTIVE TOXICOLOGY, 2010, 29 (03) : 332 - 338
  • [33] Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma
    Derenzini, Enrico
    Casadei, Beatrice
    Broccoli, Alessandro
    Gandolfi, Letizia
    Pellegrini, Cinzia
    Zinzani, Pier Luigi
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (04) : 625 - 628
  • [34] Fludarabine, Cyclophosphamide and Dexamethasone (FLUCYD) for the treatment of advanced low-grade non-Hodgkin's lymphoma.
    Lazzarino, M
    Orlandi, E
    Montillo, M
    Tedeschi, A
    Pagnucco, G
    Astori, C
    Crugnola, M
    Gargantini, L
    Corso, A
    Brusamolino, E
    Morra, E
    Bernasconi, C
    BLOOD, 1997, 90 (10) : 1533 - 1533
  • [35] CNOP (Mitoxantrone) chemotherapy is inferior to CHOP (Doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (Review).
    Bjorkholm, Magnus
    Osby, Eva
    Andersson, Tomas
    Ahlbom, Anders
    BLOOD, 2006, 108 (11) : 689A - 690A
  • [36] Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma
    Dann, EJ
    Epelbaum, R
    Avivi, I
    Ben Shahar, M
    Haim, N
    Rowe, JM
    Blumenfeld, Z
    HUMAN REPRODUCTION, 2005, 20 (08) : 2247 - 2249
  • [37] Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjogren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas
    Voulgarelis, M
    Giannouli, S
    Anagnostou, D
    Tzioufas, AG
    RHEUMATOLOGY, 2004, 43 (08) : 1050 - 1053
  • [38] Oral fludarabine/cyclophosphamide combination in pretreated indolent non-Hodgkin's lymphoma
    Fina, M
    Musuraca, G
    Alinari, L
    Stefoni, V
    Tani, M
    Gabriele, A
    Marchi, E
    Pileri, S
    Baccarani, M
    Zinzani, PL
    ANNALS OF ONCOLOGY, 2005, 16 : 151 - 151
  • [39] Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin- or mitoxantrone- containing regimen.
    Gregory, SA
    Vose, J
    Modiano, J
    Kraemer, K
    Rifkin, R
    Rubin, A
    Menduni, T
    Ghalie, RG
    BLOOD, 1999, 94 (10) : 95A - 95A
  • [40] Treatment of relapsed non-Hodgkin's-lymphoma (NHL) with liposomal Daunoxome® in combination with cyclophosphamide, vincristine and prednisone (CDaXOP).
    Röhnisch, T
    Zippelius, A
    Vehling-Kaiser, U
    Hiller, E
    Dreyling, M
    Jung, C
    Oduncu, F
    Emmerich, B
    Hiddemann, W
    Hallek, M
    BLOOD, 1999, 94 (10) : 525A - 525A
12345